| Level/ Typ | Code | Bezeichnung | Codesystem |
|---|
| 0‑L | 100-8 | Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 101-6 | Cefoperazone [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 103-2 | Ceforanide [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 104-0 | Ceforanide [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 105-7 | Ceforanide [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 10653-4 | Clotrimazole [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 10654-2 | Clotrimazole [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 10697-1 | Nystatin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 10698-9 | Nystatin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 10720-1 | Terbinafine [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 10721-9 | Terbinafine [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 107-3 | Cefotaxime [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 108-1 | Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 10868-8 | Bacitracin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 109-9 | Cefotaxime [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 121-4 | Cefpodoxime [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 111-5 | Cefotetan [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 112-3 | Cefotetan [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 113-1 | Cefotetan [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 115-6 | Cefoxitin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 11575-8 | Cefmetazole [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 11576-6 | Erythromycin+Sulfisoxazole [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 11577-4 | Sulfamethoxazole [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 11578-2 | Sulfisoxazole [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 116-4 | Cefoxitin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 11-7 | Amikacin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 117-2 | Cefoxitin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 129-7 | Cefsulodin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 119-8 | Cefpodoxime [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 120-6 | Cefpodoxime [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 123-0 | Cefprozil [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 124-8 | Cefprozil [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 12-5 | Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 125-5 | Cefprozil [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 138-8 | Ceftizoxime [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 127-1 | Cefsulodin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 128-9 | Cefsulodin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 132-1 | Ceftazidime [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 13-3 | Amikacin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 133-9 | Ceftazidime [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 134-7 | Ceftazidime [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 136-2 | Ceftizoxime [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 137-0 | Ceftizoxime [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 13968-3 | Penicillin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 140-4 | Ceftriaxone [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 141-2 | Ceftriaxone [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 142-0 | Ceftriaxone [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 14332-1 | Para aminosalicylate [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 144-6 | Cefuroxime Parenteral [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 145-3 | Cefuroxime Parenteral [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 152-9 | Cephaloglycin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 146-1 | Cefuroxime Parenteral [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 148-7 | Cephalexin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 149-5 | Cephalexin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 150-3 | Cephalexin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 153-7 | Cephaloglycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 154-5 | Cephaloglycin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 156-0 | Cephaloridine [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 157-8 | Cephaloridine [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 15-8 | Amoxicillin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 158-6 | Cephaloridine [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 160-2 | Cephalothin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 16099-4 | Ethionamide [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 161-0 | Cephalothin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 16100-0 | Rifabutin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 162-8 | Cephalothin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 16387-3 | Rifabutin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 16421-0 | Azithromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 164-4 | Cephapirin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 165-1 | Cephapirin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 16-6 | Amoxicillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 16620-7 | Clarithromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 16623-1 | Clofazimine [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 166-9 | Cephapirin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 16830-2 | Erythromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 16841-9 | Ethambutol+Rifampin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 168-5 | Cephradine [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 173-5 | Chloramphenicol [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 176-8 | Chlortetracycline [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 169-3 | Cephradine [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 170-1 | Cephradine [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 172-7 | Chloramphenicol [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 17-4 | Amoxicillin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 174-3 | Chloramphenicol [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 177-6 | Chlortetracycline [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 178-4 | Chlortetracycline [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 182-6 | Cinoxacin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 1-8 | Acyclovir [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 180-0 | Cinoxacin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 181-8 | Cinoxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 18946-4 | Metronidazole [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18947-2 | Mezlocillin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18948-0 | Minocycline [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18949-8 | Miocamycin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18950-6 | Moxalactam [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18951-4 | Nafcillin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18952-2 | Nalidixate [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18953-0 | Neomycin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18954-8 | Netilmicin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18955-5 | Nitrofurantoin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18956-3 | Norfloxacin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18957-1 | Novobiocin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18958-9 | Nystatin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 184-2 | Ciprofloxacin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 198-2 | Cloxacillin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 185-9 | Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 186-7 | Ciprofloxacin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 188-3 | Clarithromycin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 18855-7 | 5-Fluorocytosine [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18857-3 | Almecillin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18859-9 | Amdinocillin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18860-7 | Amikacin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18861-5 | Amoxicillin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18862-3 | Amoxicillin+Clavulanate [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18863-1 | Amphotericin B [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18864-9 | Ampicillin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18865-6 | Ampicillin+Sulbactam [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18866-4 | Azithromycin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18867-2 | Azlocillin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18868-0 | Aztreonam [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18869-8 | Bacampicillin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18870-6 | Bacitracin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18871-4 | Butirosin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18872-2 | Capreomycin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18873-0 | Carbenicillin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18874-8 | Cefaclor [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18875-5 | Cefadroxil [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18876-3 | Cefamandole [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18877-1 | Cefatrizine [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18878-9 | Cefazolin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18879-7 | Cefepime [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18880-5 | Cefixime [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18881-3 | Cefmetazole [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18882-1 | Cefodizime [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18883-9 | Cefonicid [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18884-7 | Cefoperazone [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18885-4 | Ceforanide [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18886-2 | Cefotaxime [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18887-0 | Cefotetan [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18888-8 | Cefoxitin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18889-6 | Cefpirome [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18890-4 | Cefpodoxime [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18891-2 | Cefprozil [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18892-0 | Cefsulodin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18893-8 | Ceftazidime [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18894-6 | Ceftizoxime [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18895-3 | Ceftriaxone [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18896-1 | Cefuroxime Parenteral [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18897-9 | Cephalexin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18898-7 | Cephaloglycin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18899-5 | Cephaloridine [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18900-1 | Cephalothin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18901-9 | Cephapirin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18902-7 | Cephradine [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18903-5 | Chloramphenicol [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18904-3 | Chlortetracycline [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18905-0 | Cinoxacin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18906-8 | Ciprofloxacin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18907-6 | Clarithromycin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18908-4 | Clindamycin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18909-2 | Clotrimazole [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 189-1 | Clarithromycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 18910-0 | Cloxacillin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18911-8 | Colistimethate | Logical Observation Identifier Names and Codes |
| 0‑L | 18912-6 | Colistin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18913-4 | Cyclacillin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18914-2 | Cycloserine [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18915-9 | Demeclocycline [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18916-7 | Dicloxacillin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18917-5 | Doxycycline [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18918-3 | Enoxacin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18919-1 | Erythromycin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18920-9 | Erythromycin+Sulfisoxazole [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18921-7 | Ethambutol [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18922-5 | Ethionamide [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18923-3 | Floxacillin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18924-1 | Fluconazole [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18926-6 | Framycetin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18927-4 | Fusidate [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18928-2 | Gentamicin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18929-0 | Gentamicin.high potency [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18930-8 | Gramicidin D [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18931-6 | Hetacillin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18932-4 | Imipenem [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18934-0 | Isoniazid [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18935-7 | Kanamycin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18936-5 | Kanamycin.high potency [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18937-3 | Ketoconazole [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18938-1 | Lincomycin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18939-9 | Lomefloxacin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18940-7 | Loracarbef [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18941-5 | Lymecycline [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18942-3 | Meclocycline [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18943-1 | Meropenem [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18944-9 | Methacycline [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18945-6 | Methicillin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18959-7 | Ofloxacin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18960-5 | Oleandomycin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18961-3 | Oxacillin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18962-1 | Oxytetracycline [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18963-9 | Pefloxacin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18964-7 | Penicillin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18965-4 | Penicillin G [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18966-2 | Penicillin V [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18967-0 | Phenethicillin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18968-8 | Pipemidate [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18969-6 | Piperacillin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18970-4 | Piperacillin+Tazobactam [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18971-2 | Pivampicillin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18972-0 | Polymyxin B [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18973-8 | Pyrazinamide [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18974-6 | Rifampin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18975-3 | Ristocetin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18976-1 | Rolitetracycline [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18977-9 | Rosoxacin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18978-7 | Roxithromycin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18979-5 | Sisomicin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18980-3 | Spectinomycin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18981-1 | Spiramycin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18982-9 | Streptomycin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18983-7 | Streptomycin.high potency [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18984-5 | Sulfadiazine [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18985-2 | Sulfamethoxazole [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18986-0 | Sulfisoxazole [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18987-8 | Sulfonamide [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18988-6 | Talampicillin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18989-4 | Teicoplanin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18990-2 | Temafloxacin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18991-0 | Temocillin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18992-8 | Terbinafine [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18993-6 | Tetracycline [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18994-4 | Ticarcillin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18995-1 | Ticarcillin+Clavulanate [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18996-9 | Tobramycin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18997-7 | Trimethoprim [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18998-5 | Trimethoprim+Sulfamethoxazole [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 18999-3 | Troleandomycin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 19-0 | Amoxicillin+Clavulanate [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 19000-9 | Vancomycin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 19001-7 | Viomycin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 190-9 | Clarithromycin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 19149-4 | Rifabutin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 192-5 | Clindamycin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 193-3 | Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 194-1 | Clindamycin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 20375-2 | Clarithromycin [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 20376-0 | Clofazimine [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 20377-8 | Ciprofloxacin [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 20378-6 | Ceftizoxime [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 20379-4 | Doxycycline [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 196-6 | Cloxacillin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 197-4 | Cloxacillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 200-6 | Colistimethate by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 201-4 | Colistimethate by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 202-2 | Colistimethate by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 20373-7 | Amikacin [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 20374-5 | Ampicillin+Sulbactam [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 20380-2 | Erythromycin [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 20381-0 | Ethambutol [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 20382-8 | Ethionamide [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 20383-6 | Isoniazid [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 20384-4 | Ofloxacin [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 20385-1 | Rifampin [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 20386-9 | Rifabutin [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 20387-7 | Trimethoprim+Sulfamethoxazole [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 20388-5 | Nitrofurazone [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 20389-3 | Mupirocin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 20390-1 | Silver sulfadiazine [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 20391-9 | Mafenide [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 20396-8 | Levofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 20397-6 | Sparfloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 20460-2 | Cefuroxime Oral [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 20461-0 | Pyrazinamide [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 20462-8 | Streptomycin [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 204-8 | Colistin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 205-5 | Colistin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 20629-2 | Levofloxacin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 206-3 | Colistin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 209-7 | Cyclacillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 20-8 | Amoxicillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 208-9 | Cyclacillin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 210-5 | Cyclacillin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 21070-8 | Other Antibiotic [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 212-1 | Cycloserine [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 21316-5 | Grepafloxacin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 21367-8 | Levofloxacin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 213-9 | Cycloserine [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 214-7 | Cycloserine [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 21-6 | Amoxicillin+Clavulanate [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 216-2 | Demeclocycline [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 217-0 | Demeclocycline [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 23636-4 | Cefdinir [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 23637-2 | Cefdinir [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 23638-0 | Grepafloxacin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 23639-8 | Grepafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 23640-6 | Quinupristin+Dalfopristin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 218-8 | Demeclocycline [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 220-4 | Dicloxacillin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 221-2 | Dicloxacillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 222-0 | Dicloxacillin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 225-3 | Doxycycline [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 224-6 | Doxycycline [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 226-1 | Doxycycline [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 228-7 | Enoxacin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 229-5 | Enoxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 230-3 | Enoxacin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 23-2 | Amphotericin B [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 232-9 | Erythromycin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 233-7 | Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 234-5 | Erythromycin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 236-0 | Erythromycin+Sulfisoxazole [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 23607-5 | Capreomycin [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 23608-3 | Cycloserine [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 23609-1 | Kanamycin [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 23610-9 | Sparfloxacin [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 23611-7 | Para aminosalicylate [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 23612-5 | Azithromycin [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 23613-3 | Imipenem [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 23614-1 | Trimethoprim [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 23615-8 | Vancomycin [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 23616-6 | Viomycin [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 23627-3 | Clofazimine [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 23628-1 | Sparfloxacin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 23629-9 | Para aminosalicylate [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 23641-4 | Quinupristin+Dalfopristin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 23642-2 | Trovafloxacin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 23643-0 | Trovafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 23658-8 | Other Antibiotic [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 23659-6 | Apramycin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 23709-9 | Ceftiofur [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 23712-3 | Enrofloxacin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 23740-4 | Florfenicol [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 24-0 | Amphotericin B [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 237-8 | Erythromycin+Sulfisoxazole [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 238-6 | Erythromycin+Sulfisoxazole [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 23925-1 | Penicillin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 244-4 | Floxacillin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 240-2 | Ethambutol [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 241-0 | Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 242-8 | Ethambutol [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 245-1 | Floxacillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 246-9 | Floxacillin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 249-3 | Fluconazole [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 252-7 | 5-Fluorocytosine [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 248-5 | Fluconazole [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 25452-4 | Itraconazole [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 25-7 | Amphotericin B [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 257-6 | Framycetin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 250-1 | Fluconazole [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 25174-4 | Amikacin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25175-1 | Amikacin 16 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25176-9 | Amikacin 32 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25177-7 | Amikacin 12 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25178-5 | Amikacin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25179-3 | Amikacin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25180-1 | Ciprofloxacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25181-9 | Ciprofloxacin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25182-7 | Kanamycin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25183-5 | Ethionamide 11 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25184-3 | Rifampin 14 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25185-0 | Streptomycin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25186-8 | Pyrazinamide 25 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25187-6 | Ethambutol 7.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25188-4 | Ciprofloxacin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25189-2 | Ciprofloxacin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25190-0 | Clarithromycin 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25191-8 | Clarithromycin 16 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25192-6 | Clarithromycin 32 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25194-2 | Ethambutol 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25195-9 | Ethambutol 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25196-7 | Ethionamide 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25198-3 | Ethionamide 15 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25199-1 | Rifabutin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25200-7 | Rifabutin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25201-5 | Rifabutin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25202-3 | Rifampin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25203-1 | Rifampin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25204-9 | Rifampin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25205-6 | Streptomycin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25206-4 | Streptomycin 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25207-2 | Cycloserine 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25208-0 | Cycloserine 20 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25209-8 | Cycloserine 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25210-6 | Capreomycin 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25211-4 | Capreomycin 20 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25212-2 | Capreomycin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25213-0 | Kanamycin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25214-8 | Kanamycin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25215-5 | Para aminosalicylate 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25216-3 | Para aminosalicylate 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25217-1 | Isoniazid 0.1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25218-9 | Isoniazid 0.2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25219-7 | Isoniazid 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25220-5 | Cefoxitin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25221-3 | Imipenem 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25222-1 | Cefmetazole 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25223-9 | Doxycycline 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25224-7 | Erythromycin 15 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25225-4 | Minocycline 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25226-2 | Sulfisoxazole 300 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25227-0 | Tobramycin 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25228-8 | Vancomycin 30 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25229-6 | Pyrazinamide 100 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25230-4 | Ethambutol 2.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25231-2 | Ethionamide 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25310-4 | Amoxicillin+Clavulanate [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 253-5 | 5-Fluorocytosine [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 25366-6 | Cefoxitin [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25367-4 | Ceftriaxone [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 25411-0 | Fleroxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 254-3 | 5-Fluorocytosine [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 25595-0 | Econazole [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 25596-8 | Fosfomycin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 25597-6 | Josamycine [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 25607-3 | Miconazole [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 25608-1 | Nitroxoline [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 25637-0 | Econazole [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 25653-7 | Fosfomycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 256-8 | Foscarnet [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 25702-2 | Josamycine [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 25722-0 | Miconazole [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 25723-8 | Nitroxoline [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 25800-4 | Tobramycin [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 258-4 | Framycetin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 259-2 | Framycetin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 2-6 | Almecillin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 274-1 | Hetacillin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 261-8 | Fusidate [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 262-6 | Fusidate [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 263-4 | Fusidate [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 265-9 | Ganciclovir [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 266-7 | Gentamicin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 267-5 | Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 268-3 | Gentamicin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 278-2 | Imipenem [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 270-9 | Gramicidin D [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 271-7 | Gramicidin D [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 272-5 | Gramicidin D [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 27-3 | Ampicillin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 276-6 | Hetacillin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 275-8 | Hetacillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 279-0 | Imipenem [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 280-8 | Imipenem [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 28-1 | Ampicillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 286-5 | Isoniazid [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 287-3 | Isoniazid [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 288-1 | Isoniazid [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 290-7 | Kanamycin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 291-5 | Kanamycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 292-3 | Kanamycin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 29254-0 | Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 29255-7 | Linezolid [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 29258-1 | Linezolid [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 29315-9 | Isoniazid 0.4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 294-9 | Ketoconazole [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 296-4 | Ketoconazole [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 298-0 | Lincomycin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 295-6 | Ketoconazole [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 29-9 | Ampicillin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 299-8 | Lincomycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 300-4 | Lincomycin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 302-0 | Lomefloxacin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 308-7 | Loracarbef [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 30268-7 | Zidovudine [Susceptibility] by Phenotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 30269-5 | Lamivudine [Susceptibility] by Phenotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 30270-3 | Didanosine [Susceptibility] by Phenotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 30271-1 | Zalcitabine [Susceptibility] by Phenotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 30272-9 | Stavudine [Susceptibility] by Phenotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 30273-7 | Abacavir [Susceptibility] by Phenotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 30274-5 | Adefovir [Susceptibility] by Phenotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 30275-2 | Nevirapine [Susceptibility] by Phenotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 30276-0 | Delavirdine [Susceptibility] by Phenotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 30277-8 | Efavirenz [Susceptibility] by Phenotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 30278-6 | Indinavir [Susceptibility] by Phenotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 30279-4 | Ritonavir [Susceptibility] by Phenotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 30280-2 | Nelfinavir [Susceptibility] by Phenotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 30281-0 | Saquinavir [Susceptibility] by Phenotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 30282-8 | Zidovudine [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 30283-6 | Lamivudine [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 30284-4 | Didanosine [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 30285-1 | Zalcitabine [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 30286-9 | Stavudine [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 30287-7 | Abacavir [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 30288-5 | Adefovir [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 30289-3 | Nevirapine [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 30290-1 | Delavirdine [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 30291-9 | Efavirenz [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 30292-7 | Indinavir [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 30293-5 | Ritonavir [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 30294-3 | Nelfinavir [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 30295-0 | Saquinavir [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 30296-8 | Amprenavir [Susceptibility] by Phenotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 30297-6 | Amprenavir [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 30298-4 | Lamivudine [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 30299-2 | Amprenavir [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 30300-8 | Didanosine [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 30301-6 | Zalcitabine [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 30302-4 | Stavudine [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 30303-2 | Abacavir [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 30304-0 | Adefovir [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 30305-7 | Delavirdine [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 30306-5 | Efavirenz [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 30307-3 | Indinavir [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 30308-1 | Ritonavir [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 30309-9 | Nelfinavir [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 30310-7 | Saquinavir [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 30311-5 | Nevirapine [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 303-8 | Lomefloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 304-6 | Lomefloxacin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 306-1 | Loracarbef [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 307-9 | Loracarbef [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 310-3 | Lymecycline [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 31036-7 | Gatifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 31037-5 | Moxifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 31038-3 | Gatifloxacin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 31039-1 | Moxifloxacin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 31040-9 | Gatifloxacin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 31041-7 | Moxifloxacin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 31042-5 | Gatifloxacin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 31043-3 | Moxifloxacin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 311-1 | Lymecycline [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 31138-1 | Cefotaxime.meningitis [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 31139-9 | Cefotaxime.meningitis [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 31140-7 | Ceftriaxone.meningitis [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 31141-5 | Ceftriaxone.meningitis [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 31142-3 | Cefepime.meningitis [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 31143-1 | Cefepime.meningitis [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 312-9 | Lymecycline [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 314-5 | Meclocycline [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 31-5 | Ampicillin+Sulbactam [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 315-2 | Meclocycline [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 316-0 | Meclocycline [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 32-3 | Ampicillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 318-6 | Methacycline [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 319-4 | Methacycline [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 320-2 | Methacycline [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 335-0 | Minocycline [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 322-8 | Methicillin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 323-6 | Methicillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 32372-5 | Fleroxacin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 32373-3 | Arbekacin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 32374-1 | Cefotiam [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 32375-8 | Cefmenoxime [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 32376-6 | Clinafloxacin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 32377-4 | Cefetamet [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 32378-2 | Caspofungin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 32379-0 | Voriconazole [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 32381-6 | Isepamicin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 32383-2 | Pristinamycin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 32384-0 | Thiacetazone [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 324-4 | Methicillin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 32597-7 | Natamycin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 32603-3 | Itraconazole [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 326-9 | Metronidazole [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 327-7 | Metronidazole [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 328-5 | Metronidazole [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 330-1 | Mezlocillin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 33-1 | Ampicillin+Sulbactam [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 331-9 | Mezlocillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 332-7 | Mezlocillin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 33332-8 | Linezolid [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 33333-6 | Colistin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 33334-4 | Quinupristin+Dalfopristin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 334-3 | Minocycline [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 33627-1 | Tenofovir [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 33628-9 | Cidofovir [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 336-8 | Minocycline [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 338-4 | Miocamycin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 339-2 | Miocamycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 3-4 | Almecillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 340-0 | Miocamycin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 342-6 | Moxalactam [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 343-4 | Moxalactam [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 344-2 | Moxalactam [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 34643-7 | Lopinavir [Susceptibility] by Phenotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 34644-5 | Tenofovir [Susceptibility] by Phenotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 346-7 | Nafcillin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 347-5 | Nafcillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 348-3 | Nafcillin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 350-9 | Nalidixate [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 351-7 | Nalidixate [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 36-4 | Azithromycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 352-5 | Nalidixate [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 354-1 | Neomycin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 35863-0 | Voriconazole [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 355-8 | Neomycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 35-6 | Azithromycin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 356-6 | Neomycin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35754-1 | Avilamycin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35755-8 | Avilamycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 35756-6 | Avilamycin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 35757-4 | Cefdinir [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 35758-2 | Cefdinir [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35759-0 | Cefditoren [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35760-8 | Cefditoren [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 35761-6 | Cefditoren [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 35762-4 | Cefditoren [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 35763-2 | Cefepime+Clavulanate [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 35764-0 | Cefetamet [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35765-7 | Cefetamet [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 35766-5 | Cefixime [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 35767-3 | Cefoperazone [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 35768-1 | Cefoperazone+Sulbactam [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 35769-9 | Cefotaxime+Clavulanate [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35770-7 | Cefotaxime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 35771-5 | Cefotaxime+Clavulanate [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 35772-3 | Cefotiam [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35773-1 | Cefotiam [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 35774-9 | Ceftazidime+Clavulanate [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35775-6 | Ceftazidime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 35776-4 | Ceftazidime+Clavulanate [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 35777-2 | Ceftibuten [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35778-0 | Ceftibuten [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 35779-8 | Ceftibuten [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 35780-6 | Ceftiofur [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35781-4 | Ceftiofur [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 35782-2 | Cefuroxime Oral [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35783-0 | Cefuroxime Oral [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 35784-8 | Cephalexin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 35785-5 | Clinafloxacin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35786-3 | Clinafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 35787-1 | Daptomycin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35788-9 | Daptomycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 35789-7 | Daptomycin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 35790-5 | Difloxacin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35791-3 | Difloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 35792-1 | Difloxacin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 35793-9 | Dirithromycin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35794-7 | Dirithromycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 35795-4 | Dirithromycin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 35796-2 | Enrofloxacin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 35797-0 | Enrofloxacin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35798-8 | Enrofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 35799-6 | Ertapenem [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35800-2 | Ertapenem [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 35801-0 | Ertapenem [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 35802-8 | Ertapenem [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 35803-6 | Bambermycins [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35804-4 | Bambermycins [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 35805-1 | Bambermycins [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 35806-9 | Fleroxacin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35807-7 | Florfenicol [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35808-5 | Florfenicol [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 35809-3 | Fosfomycin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 35810-1 | Fosfomycin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35811-9 | Garenoxacin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35812-7 | Garenoxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 35813-5 | Garenoxacin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 35814-3 | Gemifloxacin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35815-0 | Gemifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 35816-8 | Gemifloxacin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 35817-6 | Gentamicin.high potency [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 35818-4 | Grepafloxacin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35819-2 | Imipenem+EDTA [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 358-2 | Netilmicin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 35820-0 | Isepamicin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35821-8 | Isepamicin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 35822-6 | Mupirocin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35823-4 | Mupirocin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 35824-2 | Nystatin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35825-9 | Orbifloxacin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35826-7 | Orbifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 35827-5 | Orbifloxacin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 35828-3 | Pefloxacin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35829-1 | Pirlimycin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35830-9 | Pirlimycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 35831-7 | Pirlimycin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 35832-5 | Polymyxin B [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 35833-3 | Pristinamycin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35834-1 | Pristinamycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 35835-8 | Quinupristin+Dalfopristin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35836-6 | Salinomycin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35837-4 | Salinomycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 35838-2 | Salinomycin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 35839-0 | Sparfloxacin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35840-8 | Spectinomycin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 35841-6 | Streptomycin.high potency [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 35842-4 | Sulfonamide [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 35843-2 | Telithromycin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35844-0 | Telithromycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 35845-7 | Telithromycin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 35846-5 | Tiamulin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35847-3 | Tiamulin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 35848-1 | Tiamulin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 35849-9 | Tilmicosin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35850-7 | Tilmicosin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 35851-5 | Tilmicosin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 35852-3 | Trospectinomycin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35853-1 | Trospectinomycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 35854-9 | Trospectinomycin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 35855-6 | Trovafloxacin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35856-4 | Tylosin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35857-2 | Tylosin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 35858-0 | Tylosin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 35859-8 | Virginiamycin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35860-6 | Virginiamycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 35861-4 | Virginiamycin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 35862-2 | Voriconazole [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 35872-1 | Penicillin+Novobiocin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 35873-9 | Penicillin+Novobiocin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 35874-7 | Penicillin+Novobiocin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 359-0 | Netilmicin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 360-8 | Netilmicin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 362-4 | Nitrofurantoin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 363-2 | Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 364-0 | Nitrofurantoin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 366-5 | Norfloxacin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 367-3 | Norfloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 368-1 | Norfloxacin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 370-7 | Novobiocin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 371-5 | Novobiocin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 37-2 | Azithromycin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 372-3 | Novobiocin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 374-9 | Ofloxacin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 375-6 | Ofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 376-4 | Ofloxacin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 392-1 | Penicillin G [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 378-0 | Oleandomycin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 379-8 | Oleandomycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 380-6 | Oleandomycin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 382-2 | Oxacillin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 383-0 | Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 384-8 | Oxacillin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 386-3 | Oxytetracycline [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 387-1 | Oxytetracycline [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 388-9 | Oxytetracycline [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 390-5 | Pefloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 391-3 | Penicillin G [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 393-9 | Penicillin G [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 395-4 | Penicillin V [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 396-2 | Penicillin V [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 397-0 | Penicillin V [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 39-8 | Azlocillin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 399-6 | Phenethicillin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 400-2 | Phenethicillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 401-0 | Phenethicillin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 403-6 | Pipemidate [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 404-4 | Pipemidate [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 405-1 | Pipemidate [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 40-6 | Azlocillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 407-7 | Piperacillin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 408-5 | Piperacillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 409-3 | Piperacillin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 41408-6 | Ofloxacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 41409-4 | Ofloxacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 41410-2 | Ofloxacin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 41031-6 | Lopinavir [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 41993-7 | Atazanavir [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 411-9 | Piperacillin+Tazobactam [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 41199-1 | Voriconazole [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 41200-7 | Voriconazole [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 412-7 | Piperacillin+Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 413-5 | Piperacillin+Tazobactam [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 41396-3 | Tenofovir [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 41-4 | Azlocillin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 41402-9 | Emtricitabine [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 41403-7 | Atazanavir [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 41494-6 | Gatifloxacin [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 415-0 | Pivampicillin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 41500-0 | Linezolid [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 41502-6 | Moxifloxacin [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 41504-2 | Norfloxacin [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 41658-6 | ABT492 [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 41659-4 | ABT492 [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 41660-2 | ABT492 [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 41661-0 | Azlocillin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 41662-8 | Aztreonam+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 41663-6 | Aztreonam+Clavulanate [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 41664-4 | Aztreonam+Clavulanate [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 41665-1 | Biapenem [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 41666-9 | Biapenem [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 41667-7 | Biapenem [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 41668-5 | Carbenicillin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 41669-3 | Cefamandole [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 41670-1 | Cefazolin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 41671-9 | Cefotaxime+Clavulanate [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 41672-7 | Cefotetan+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 41673-5 | Cefotetan+Clavulanate [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 41674-3 | Cefotetan+Clavulanate [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 41675-0 | Cefoxitin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 41676-8 | Cefoxitin+Clavulanate [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 41677-6 | Cefoxitin+Clavulanate [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 41678-4 | Cefpodoxime+Clavulanate [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 41679-2 | Cefpodoxime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 416-8 | Pivampicillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 41680-0 | Cefpodoxime+Clavulanate [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 41681-8 | Ceftriaxone+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 41682-6 | Ceftriaxone+Clavulanate [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 41683-4 | Ceftriaxone+Clavulanate [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 41684-2 | Cephaloridine [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 41685-9 | Clavulanate [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 41686-7 | Clavulanate [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 41687-5 | Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 41688-3 | Dalbavancin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 41689-1 | Dalbavancin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 41690-9 | Dalbavancin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 41691-7 | Daptomycin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 41692-5 | Enoxacin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 41693-3 | Ethionamide [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 41694-1 | Everninomicin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 41695-8 | Everninomicin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 41696-6 | Everninomicin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 41697-4 | Gemifloxacin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 41698-2 | Josamycine [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 41699-0 | Josamycine [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 41700-6 | Lincomycin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 41701-4 | Lomefloxacin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 41702-2 | Mezlocillin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 41703-0 | Moxalactam [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 41704-8 | Nafcillin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 41705-5 | Neomycin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 41706-3 | Novobiocin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 41707-1 | Oritavancin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 41708-9 | Oritavancin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 41709-7 | Oritavancin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 41710-5 | Ramoplanin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 41711-3 | Ramoplanin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 41712-1 | Ramoplanin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 41713-9 | Rosamicin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 41714-7 | Rosamicin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 41715-4 | Rosamicin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 41716-2 | Sulbactam [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 41717-0 | Sulbactam [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 41718-8 | Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 41719-6 | Tazobactam [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 41720-4 | Tazobactam [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 41721-2 | Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 41722-0 | Telithromycin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 41723-8 | Thiamphenicol [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 41724-6 | Thiamphenicol [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 41725-3 | Thiamphenicol [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 41726-1 | ABT492 [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 41727-9 | Aztreonam+Clavulanate [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 41728-7 | Biapenem [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 41729-5 | Cefotetan+Clavulanate [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 41730-3 | Cefoxitin+Clavulanate [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 41731-1 | Cefpodoxime+Clavulanate [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 41732-9 | Ceftriaxone+Clavulanate [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 41733-7 | Clavulanate [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 41734-5 | Dalbavancin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 41735-2 | Everninomicin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 41736-0 | Oritavancin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 41737-8 | Ramoplanin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 41738-6 | Rosamicin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 41739-4 | Sulbactam [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 41740-2 | Tazobactam [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 417-6 | Pivampicillin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 419-2 | Polymyxin B [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 4-2 | Almecillin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 420-0 | Polymyxin B [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 42000-0 | Lopinavir+Ritonavir [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 421-8 | Polymyxin B [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 42317-8 | Foscarnet [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 423-4 | Pyrazinamide [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 42350-9 | Cefepime+Clavulanate [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 42351-7 | Cefepime+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 42352-5 | Ceftazidime+Clavulanate [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 42353-3 | Cefepime+Clavulanate [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 42354-1 | Tigecycline [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 42355-8 | Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 42356-6 | Tigecycline [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 42357-4 | Tigecycline [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 424-2 | Pyrazinamide [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 42500-9 | Fosamprenavir [Susceptibility] by Phenotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 42535-5 | Tipranavir [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 425-9 | Pyrazinamide [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 42642-9 | Amikacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 42651-0 | Isoniazid 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 42655-1 | Rifabutin 0.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 42720-3 | Clindamycin.induced [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 427-5 | Rifampin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 428-3 | Rifampin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 429-1 | Rifampin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 43-0 | Aztreonam [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 431-7 | Ristocetin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 432-5 | Ristocetin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 43269-0 | Ceftobiprole [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 43270-8 | Ceftobiprole [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 43271-6 | Ceftobiprole [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 43272-4 | Ceftobiprole [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 433-3 | Ristocetin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 435-8 | Rolitetracycline [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 436-6 | Rolitetracycline [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 43736-8 | Fosamprenavir [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 43737-6 | Tipranavir [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 437-4 | Rolitetracycline [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 439-0 | Rosoxacin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 43986-9 | Clofazimine 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 43987-7 | Clarithromycin 12 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 43988-5 | Clofazimine 0.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 43989-3 | Clofazimine 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 43990-1 | Clarithromycin 3 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 43991-9 | Clarithromycin 6 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 440-8 | Rosoxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 441-6 | Rosoxacin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 443-2 | Roxithromycin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 444-0 | Roxithromycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 445-7 | Roxithromycin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 447-3 | Sisomicin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 44-8 | Aztreonam [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 448-1 | Sisomicin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 449-9 | Sisomicin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 451-5 | Spectinomycin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 45182-3 | HIV phenotype [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 45187-2 | Other Antibiotic [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 45215-1 | Isoniazid 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 452-3 | Spectinomycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 453-1 | Spectinomycin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 45-5 | Aztreonam [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 455-6 | Spiramycin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 456-4 | Spiramycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 457-2 | Spiramycin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 459-8 | Streptomycin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 460-6 | Streptomycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 461-4 | Streptomycin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 465-5 | Sulfadiazine [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 463-0 | Sulfadiazine [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 464-8 | Sulfadiazine [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 467-1 | Sulfamethoxazole [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 46719-1 | Streptomycin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 468-9 | Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 469-7 | Sulfamethoxazole [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 47-1 | Bacampicillin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 471-3 | Sulfisoxazole [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 472-1 | Sulfisoxazole [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 473-9 | Sulfisoxazole [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 475-4 | Sulfonamide [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 476-2 | Sulfonamide [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 477-0 | Sulfonamide [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 48169-7 | Amikacin 1.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 48170-5 | Capreomycin 3 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 48173-9 | Levofloxacin 1.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 48558-1 | HIV genotype [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 479-6 | Talampicillin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 480-4 | Talampicillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 481-2 | Talampicillin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 48177-0 | Streptomycin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 483-8 | Teicoplanin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 484-6 | Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 485-3 | Teicoplanin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 48685-2 | Para aminosalicylate 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 487-9 | Temafloxacin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 488-7 | Temafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 48-9 | Bacampicillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 489-5 | Temafloxacin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 49080-5 | Kanamycin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 491-1 | Temocillin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 492-9 | Temocillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 493-7 | Temocillin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 495-2 | Tetracycline [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 49573-9 | HIV genotype [Susceptibility] in Isolate by Genotype method Narrative | Logical Observation Identifier Names and Codes |
| 0‑L | 496-0 | Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 49618-2 | Atazanavir+Ritonavir [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 49619-0 | Indinavir+Ritonavir [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 49620-8 | Lamivudine or Emtricitabine [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 49621-6 | Saquinavir+Ritonavir [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 49622-4 | Tipranavir+Ritonavir [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 49623-2 | Amprenavir or Fosamprenavir [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 49630-7 | Darunavir+Ritonavir [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 49666-1 | Darunavir [Susceptibility] by Phenotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 49667-9 | Tipranavir [Susceptibility] by Phenotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 49668-7 | Atazanavir [Susceptibility] by Phenotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 49669-5 | Emtricitabine [Susceptibility] by Phenotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 49-7 | Bacampicillin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 497-8 | Tetracycline [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 511-6 | Trimethoprim [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 499-4 | Ticarcillin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 500-9 | Ticarcillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 504-1 | Ticarcillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 50630-3 | Gentamicin [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 50631-1 | Cefepime [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 50632-9 | Cefotaxime [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 50633-7 | Ceftriaxone.meningitis [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 501-7 | Ticarcillin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 503-3 | Ticarcillin+Clavulanate [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 505-8 | Ticarcillin+Clavulanate [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 50703-8 | Influenza virus A.neuraminidase inhibitor resistance [Susceptibility] Qualitative by Phenotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 50712-9 | Influenza virus.neuraminidase inhibitor resistance [Susceptibility] Qualitative | Logical Observation Identifier Names and Codes |
| 0‑L | 50713-7 | Influenza virus.neuraminidase inhibitor resistance [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 507-4 | Tobramycin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 508-2 | Tobramycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 509-0 | Tobramycin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 51698-9 | Dapsone [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 512-4 | Trimethoprim [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 51-3 | Butirosin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 513-2 | Trimethoprim [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 51409-1 | Fosamprenavir+Ritonavir [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 51719-3 | Paromomycin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 51503-1 | Penicillin G procaine [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 51504-9 | Penicillin G benzathine [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 515-7 | Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 516-5 | Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 51694-8 | Carumonam [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 51724-3 | Cefuroxime [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 517-3 | Trimethoprim+Sulfamethoxazole [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 52749-9 | Etravirine [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 51774-8 | Cefuroxime [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 519-9 | Troleandomycin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 520-7 | Troleandomycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 52-1 | Butirosin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 52128-6 | Cefotaxime.meningitis [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 521-5 | Troleandomycin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 523-1 | Vancomycin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 524-9 | Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 525-6 | Vancomycin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 527-2 | Viomycin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 528-0 | Viomycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 529-8 | Viomycin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 531-4 | Zidovudine [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 53716-7 | Levofloxacin [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 53812-4 | Micafungin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 53818-1 | Arbekacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 53820-7 | Cefozopran [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 53822-3 | Flomoxef [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 53823-1 | Panipenem [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 53824-9 | Paromomycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 53-9 | Butirosin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 54166-4 | Cefoperazone+Sulbactam [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 54167-2 | Cefoperazone+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 54168-0 | Cefoperazone+Sulbactam [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 54169-8 | Thiamphenicol [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 54170-6 | Imipenem+EDTA [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 54171-4 | Imipenem+EDTA [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 54172-2 | Imipenem+EDTA [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 54173-0 | Arbekacin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 54174-8 | Cefmenoxime [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 54175-5 | Caspofungin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 54176-3 | Caspofungin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 54177-1 | Clotrimazole [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 54178-9 | Econazole [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 54179-7 | Itraconazole [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 54180-5 | Miconazole [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 54181-3 | Nitroxoline [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 54182-1 | Para aminosalicylate [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 54183-9 | Rifabutin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 54184-7 | Thiacetazone [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 54185-4 | Caspofungin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 54186-2 | Posaconazole [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 54187-0 | Posaconazole [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 54188-8 | Posaconazole [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 54189-6 | Posaconazole [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 54190-4 | Temocillin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 54191-2 | Cefotaxime+Sulbactam [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 54192-0 | Cefotaxime+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 54193-8 | Cefotaxime+Sulbactam [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 54194-6 | Mezlocillin+Sulbactam [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 54195-3 | Mezlocillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 54196-1 | Mezlocillin+Sulbactam [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 54197-9 | Piperacillin+Sulbactam [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 54198-7 | Piperacillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 54199-5 | Piperacillin+Sulbactam [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 54200-1 | Griseofulvin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 54201-9 | Griseofulvin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 54202-7 | Griseofulvin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 54203-5 | Cefmenoxime [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 54204-3 | Thiacetazone [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 54908-9 | Cefminox [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 54928-7 | Tinidazole [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 55091-3 | Darunavir [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 55189-5 | Cefotaxime.meningitis [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 55190-3 | Ceftriaxone.meningitis [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 55136-6 | Penicillin Parenteral [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 55137-4 | Penicillin Parenteral.meningitis [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 55154-9 | Ethambutol+Rifampin [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 55156-4 | Minocycline [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 55158-0 | Tigecycline [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 55194-5 | Ciprofloxacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 55196-0 | Terconazole [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 55711-6 | Pyrazinamide 200 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 55712-4 | Rifampin 40 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 55713-2 | Rosoxacin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55714-0 | Sisomicin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55715-7 | Spiramycin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55716-5 | Ticarcillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 55717-3 | Ticarcillin+Sulbactam [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 55289-3 | Sulopenem [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 55290-1 | Sulopenem [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 55291-9 | Sulopenem [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 55292-7 | Linopristin+Flopristin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 55293-5 | Linopristin+Flopristin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 55294-3 | Linopristin+Flopristin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 55343-8 | Anidulafungin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 55-4 | Capreomycin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 55655-5 | Chlortetracycline [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55656-3 | Cinoxacin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55657-1 | Clindamycin.high potency [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 55658-9 | Clindamycin.high potency [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55659-7 | Clindamycin.high potency [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 55660-5 | Clindamycin.high potency [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 55661-3 | Clofazimine [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 55662-1 | Clofazimine [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55663-9 | Clotrimazole [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55664-7 | Cloxacillin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55614-2 | Amoxicillin+Sulbactam [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 55615-9 | Amoxicillin+Sulbactam [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55616-7 | Amoxicillin+Sulbactam [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 55617-5 | Other Antibiotic [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55618-3 | Atovaquone [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 55619-1 | Avilamycin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55620-9 | Bacampicillin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55621-7 | Bambermycins [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55622-5 | Butirosin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55623-3 | Capreomycin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55624-1 | Cefacetrile [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 55625-8 | Cefacetrile [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 55626-6 | Cefacetrile [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 55627-4 | Cefacetrile [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55628-2 | Cefadroxil [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55629-0 | Cephaloglycin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55630-8 | Cephalothin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 55631-6 | Cephalothin+Sulbactam [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 55632-4 | Cephalothin+Sulbactam [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 55633-2 | Cephalothin+Sulbactam [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55634-0 | Cefamandole+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 55635-7 | Cefamandole+Sulbactam [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 55636-5 | Cefamandole+Sulbactam [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 55637-3 | Cefamandole+Sulbactam [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55638-1 | Cephapirin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55639-9 | Cefatrizine [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55640-7 | Cefetamet [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55641-5 | Cefmenoxime [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55642-3 | Cefonicid [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55737-1 | Cefotiam hexetil [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 55738-9 | Cefotiam hexetil [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 55739-7 | Cefotiam hexetil [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 55740-5 | Cefotiam hexetil [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55643-1 | Ceforanide [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55644-9 | Cefotaxime+Sulbactam [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55645-6 | Cefotiam [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55646-4 | Cephradine [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55647-2 | Cefsulodin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55648-0 | Ceftazidime+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 55649-8 | Ceftazidime+Sulbactam [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 55650-6 | Ceftazidime+Sulbactam [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 55651-4 | Ceftazidime+Sulbactam [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55652-2 | Ceftiofur [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55653-0 | Cefuroxime Oral [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55654-8 | Cefuroxime [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55665-4 | Colistimethate by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55666-2 | Cyclacillin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55667-0 | Cycloserine [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55668-8 | Dicloxacillin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55669-6 | Dibekacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 55670-4 | Dibekacin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 55671-2 | Dibekacin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 55672-0 | Dibekacin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55673-8 | Econazole [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55674-6 | Ethambutol 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 55675-3 | Flumequine [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 55676-1 | Flumequine [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 55677-9 | Flumequine [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 55678-7 | Flumequine [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55679-5 | Framycetin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55680-3 | Isepamicin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55681-1 | Isoconazole [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 55682-9 | Isoconazole [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 55683-7 | Isoconazole [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 55684-5 | Isoconazole [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55685-2 | Isoniazid 10 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 55686-0 | Miconazole [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55687-8 | Miocamycin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55688-6 | Nitroxoline [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55689-4 | Nystatin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55690-2 | Oleandomycin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55691-0 | Ornidazole [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 55692-8 | Ornidazole [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55693-6 | Ornidazole [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 55694-4 | Ornidazole [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 55695-1 | Oxolinate [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 55696-9 | Oxolinate [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 55697-7 | Oxolinate [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 55698-5 | Oxolinate [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55699-3 | Oxytetracycline [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55701-7 | Paromomycin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 55702-5 | Paromomycin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55703-3 | Pipemidate [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55704-1 | Piperacillin+Sulbactam [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55705-8 | Piromidate [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 55706-6 | Piromidate [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 55707-4 | Piromidate [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 55708-2 | Piromidate [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55709-0 | Pristinamycin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55710-8 | Pyrazinamide [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55718-1 | Ticarcillin+Sulbactam [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 55719-9 | Ticarcillin+Sulbactam [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55720-7 | Tinidazole [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 55721-5 | Tinidazole [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 55722-3 | Tinidazole [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 55723-1 | Virginiamycin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 57-0 | Capreomycin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 56025-0 | Ethambutol 8 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 56026-8 | Pyrazinamide 300 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 56031-8 | Doripenem [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 56-2 | Capreomycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 56791-7 | Entecavir [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 56792-5 | Telbivudine [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 57095-2 | Anidulafungin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 57895-5 | Influenza virus A H1.neuraminidase inhibitor resistance [Susceptibility] in Unspecified specimen by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 57896-3 | Influenza virus A 2009 H1N1v.neuraminidase inhibitor resistance [Susceptibility] in Unspecified specimen by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 57897-1 | Influenza virus A+B.neuraminidase inhibitor resistance [Susceptibility] in Unspecified specimen by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 57907-8 | Atazanavir+Ritonavir [Susceptibility] by Phenotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 57955-7 | Darunavir+Ritonavir [Susceptibility] by Phenotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 57965-6 | Fosamprenavir+Ritonavir [Susceptibility] by Phenotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 57984-7 | Indinavir+Ritonavir [Susceptibility] by Phenotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 57997-9 | Lopinavir+Ritonavir [Susceptibility] by Phenotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 58705-5 | Ceftazidime [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 58024-1 | Saquinavir+Ritonavir [Susceptibility] by Phenotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 58029-0 | Tipranavir+Ritonavir [Susceptibility] by Phenotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 58080-3 | Penicillin Parenteral.meningitis [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 58085-2 | Penicillin Parenteral [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 58412-8 | Cefepime.meningitis [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 58711-3 | Doripenem [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 58712-1 | Quinupristin+Dalfopristin [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 59-6 | Carbenicillin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 59833-4 | Other Antibiotic [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 60-4 | Carbenicillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 60440-5 | Oseltamivir [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 60441-3 | Oseltamivir+Zanamivir [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 60535-2 | Doripenem [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 60542-8 | Mupirocin 5 ug [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 60543-6 | Mupirocin 200 ug [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 60564-2 | Amikacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 60565-9 | Amikacin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 61188-9 | Clindamycin.induced [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 61198-8 | Raltegravir [Susceptibility] by Phenotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 61-2 | Carbenicillin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 61355-4 | Capreomycin 5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 62237-3 | Carbapenemase [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 63565-6 | Prothionamide [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 63-8 | Cefadroxil [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 64-6 | Cefadroxil [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 65-3 | Cefadroxil [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 65340-2 | Micafungin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 6643-1 | Cefepime [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 6644-9 | Cefepime [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 6651-4 | Meropenem [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 6652-2 | Meropenem [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 6653-0 | Meropenem [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 6-7 | Amantadine [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 68-7 | Cefamandole [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 67-9 | Cefamandole [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 6827-0 | Bacitracin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 68463-9 | Rilpivirine [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 6932-8 | Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 6933-6 | Streptomycin.high potency [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 6998-9 | Ceftriaxone [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 6999-7 | Cefuroxime Parenteral [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7000-3 | Cephalothin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 6976-5 | Amoxicillin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7020-1 | Isoniazid [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7047-4 | Sparfloxacin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 69-5 | Cefamandole [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 69574-2 | Furazolidone [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 6975-7 | Amikacin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 6977-3 | Amoxicillin+Clavulanate [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 6978-1 | Amphotericin B [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 6979-9 | Ampicillin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 6980-7 | Ampicillin+Sulbactam [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 6981-5 | Azithromycin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 6982-3 | Aztreonam [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 6983-1 | Bacitracin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 6984-9 | Beta lactamase.extended spectrum [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 6985-6 | Beta lactamase.usual [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 6986-4 | Cefaclor [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 6987-2 | Cefepime [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 6988-0 | Cefodizime [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 6989-8 | Cefotaxime [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 6990-6 | Cefotetan [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 6991-4 | Cefoxitin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 6992-2 | Cefpirome [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 6993-0 | Cefpodoxime [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 6994-8 | Cefprozil [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 6995-5 | Ceftazidime [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 6996-3 | Ceftibuten [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 6997-1 | Ceftizoxime [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7001-1 | Chloramphenicol [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7002-9 | Ciprofloxacin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7003-7 | Clarithromycin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7004-5 | Clinafloxacin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7005-2 | Clindamycin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7006-0 | Demeclocycline [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7007-8 | Dirithromycin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7008-6 | Doxycycline [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7009-4 | Erythromycin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7010-2 | Ethambutol [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7011-0 | Ethionamide [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7012-8 | Fleroxacin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7034-2 | Nalidixate [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7039-1 | Oxacillin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7058-1 | Trovafloxacin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7013-6 | Fluconazole [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7014-4 | 5-Fluorocytosine [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7015-1 | Fusidate [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7016-9 | Gentamicin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7017-7 | Gentamicin.high potency [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 7018-5 | Gentamicin.high potency [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 7019-3 | Imipenem [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7021-9 | Itraconazole [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7022-7 | Kanamycin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7023-5 | Kanamycin.high potency [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 7024-3 | Kanamycin.high potency [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 7025-0 | Ketoconazole [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7026-8 | Levofloxacin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7027-6 | Loracarbef [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7028-4 | Amdinocillin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7029-2 | Meropenem [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7030-0 | Methicillin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7031-8 | Metronidazole [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7032-6 | Minocycline [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7033-4 | Mupirocin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7035-9 | Netilmicin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7036-7 | Nitrofurantoin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7037-5 | Norfloxacin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7038-3 | Ofloxacin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7040-9 | Pefloxacin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7041-7 | Penicillin G [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7042-5 | Penicillin V [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7043-3 | Piperacillin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7044-1 | Piperacillin+Tazobactam [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7045-8 | Rifampin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7046-6 | Roxithromycin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7048-2 | Streptomycin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7049-0 | Streptomycin.high potency [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 7050-8 | Sulfadiazine [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7051-6 | Teicoplanin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7052-4 | Tetracycline [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7053-2 | Ticarcillin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7054-0 | Ticarcillin+Clavulanate [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7055-7 | Tobramycin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7056-5 | Trimethoprim [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7057-3 | Trimethoprim+Sulfamethoxazole [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 7059-9 | Vancomycin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 71-1 | Cefatrizine [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 72557-2 | Rilpivirine [Susceptibility] by Phenotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 72558-0 | Etravirine [Susceptibility] by Phenotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 72168-8 | Ofloxacin 1.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 72525-9 | Raltegravir [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 72526-7 | Elvitegravir [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 73633-0 | Sarafloxacin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 73634-8 | Rifaximin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 73635-5 | Razupenem [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 73636-3 | Premafloxacin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 73637-1 | Plazomicin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 73638-9 | Ormetroprim+Sulfamethoxazole [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 73639-7 | Omadacycline [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 73640-5 | Nitazoxanide [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 72834-5 | Foscarnet [Susceptibility] by Phenotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 72839-4 | Famciclovir [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 72853-5 | Maribavir [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 72854-3 | Ganciclovir [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 72855-0 | Cidofovir [Susceptibility] by Phenotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 72856-8 | Cidofovir [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 72857-6 | Dolutegravir [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 72858-4 | Enfuvirtide [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 72859-2 | Boceprevir [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 72860-0 | Telaprevir [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 72861-8 | Ganciclovir [Susceptibility] by Phenotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 72893-1 | Doripenem [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 72894-9 | Telavancin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 72-9 | Cefatrizine [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 73585-2 | Tizoxanide [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 73586-0 | Tedizolid [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 73587-8 | Solithromycin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 73588-6 | Sarafloxacin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 73589-4 | Rifaximin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 73590-2 | Razupenem [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 73591-0 | Premafloxacin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 73592-8 | Plazomicin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 73619-9 | Iclaprim [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 73620-7 | Finafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 73621-5 | Fidaxomicin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 73622-3 | Faropenem [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 73623-1 | Danofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 73624-9 | Ceftolozane+Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 73574-6 | Acyclovir [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 73593-6 | Ormetroprim+Sulfamethoxazole [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 73594-4 | Omadacycline [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 73595-1 | Nitazoxanide [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 73596-9 | Marbofloxacin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 73597-7 | Iclaprim [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 73598-5 | Finafloxacin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 73599-3 | Fidaxomicin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 73600-9 | Faropenem [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 73601-7 | Danofloxacin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 73602-5 | Ceftolozane+Tazobactam [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 73603-3 | Ceftazidime+Avibactam [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 73604-1 | Ceftaroline+Avibactam [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 73605-8 | Ceftaroline [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 73606-6 | Besifloxacin [Susceptibility] | Logical Observation Identifier Names and Codes |
| 0‑L | 73607-4 | Tizoxanide [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 73608-2 | Tedizolid [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 73609-0 | Solithromycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 73610-8 | Sarafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 73611-6 | Rifaximin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 73612-4 | Razupenem [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 73613-2 | Premafloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 73614-0 | Plazomicin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 73615-7 | Ormetroprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 73616-5 | Omadacycline [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 73617-3 | Nitazoxanide [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 73618-1 | Marbofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 73625-6 | Ceftazidime+Avibactam [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 73626-4 | Ceftaroline+Avibactam [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 73627-2 | Ceftaroline [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 73628-0 | Besifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 73629-8 | Tizoxanide [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 73630-6 | Telavancin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 73631-4 | Tedizolid [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 73632-2 | Solithromycin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 73641-3 | Marbofloxacin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 73642-1 | Iclaprim [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 73643-9 | Finafloxacin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 73644-7 | Fidaxomicin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 73645-4 | Faropenem [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 73646-2 | Danofloxacin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 73647-0 | Ceftolozane+Tazobactam [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 73648-8 | Ceftazidime+Avibactam [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 73649-6 | Ceftaroline+Avibactam [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 73650-4 | Ceftaroline [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 73651-2 | Besifloxacin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 73652-0 | Apramycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 73653-8 | Apramycin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 73665-2 | Optochin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 73-7 | Cefatrizine [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 74170-2 | Ceftaroline [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 74699-0 | Cefuroxime [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 76040-5 | Levofloxacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 76041-3 | Levofloxacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 7-5 | Amdinocillin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 75029-9 | Zanamivir [Susceptibility] by Genotype method | Logical Observation Identifier Names and Codes |
| 0‑L | 75-2 | Cefazolin [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 76-0 | Cefazolin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 76042-1 | Levofloxacin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 76043-9 | Moxifloxacin 0.5 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 76044-7 | Moxifloxacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 76045-4 | Moxifloxacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 76143-7 | Cefcapene [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 76144-5 | Cefteram [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 76145-2 | Prulifloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 76146-0 | Tosufloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 76147-8 | Cefovecin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 76148-6 | Pradofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 76149-4 | Tulathromycin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 76150-2 | Cefquinome [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 76627-9 | Rifapentine [Susceptibility] by Method for Slow-growing mycobacteria | Logical Observation Identifier Names and Codes |
| 0‑L | 77162-6 | Anidulafungin [Susceptibility] by Gradient strip | Logical Observation Identifier Names and Codes |
| 0‑L | 77-8 | Cefazolin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 77960-3 | Penicillin Parenteral [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 78004-9 | Staphylococcus aureus.vancomycin resistance [Susceptibility] Qualitative | Logical Observation Identifier Names and Codes |
| 0‑L | 79-4 | Cefixime [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 80-2 | Cefixime [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 81-0 | Cefixime [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 8272-7 | Cefepime [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 8274-3 | Cefpirome [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 8275-0 | Cefpirome [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 8276-8 | Cefpirome [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 8-3 | Amdinocillin [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 83-6 | Cefaclor [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 84-4 | Cefaclor [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 85-1 | Cefaclor [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 87-7 | Cefmetazole [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 88-5 | Cefmetazole [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 89-3 | Cefmetazole [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 96-8 | Cefonicid [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 91-9 | Cefodizime [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 9-1 | Amdinocillin [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 92-7 | Cefodizime [Susceptibility] by Minimum inhibitory concentration (MIC) | Logical Observation Identifier Names and Codes |
| 0‑L | 93-5 | Cefodizime [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 95-0 | Cefonicid [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| 0‑L | 97-6 | Cefonicid [Susceptibility] by Disk diffusion (KB) | Logical Observation Identifier Names and Codes |
| 0‑L | 99-2 | Cefoperazone [Susceptibility] by Minimum lethal concentration (MLC) | Logical Observation Identifier Names and Codes |
| Dieses Value Set beinhaltet 1471 Codes. Um die Publikationsgröße überschaubar zu halten, wird nur eine Auswahl (500 Codes) des ganzen Sets von Codes gezeigt. |
|
Veraltet